News Everything that happens at IrsiCaixa, at your fingertips. Breadcrumb Home Latest news HIV Vaccines 06/03/2025 Phase II clinical trial AELIX-003 confirms that the immune response to the HTI therapeutic vaccine helps improve HIV control without treatment Achievement 04/03/2025 30 years of IrsiCaixa: the legacy of past pandemics to face those of the future Emerging pathogens 07/02/2025 Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses See all Press Contact the communications department and access our press releases. See the press area Outreach We bring science closer to society through different activities. Find out more here Social media You will also find us on social networks. Do you follow us?
HIV Vaccines 06/03/2025 Phase II clinical trial AELIX-003 confirms that the immune response to the HTI therapeutic vaccine helps improve HIV control without treatment
Achievement 04/03/2025 30 years of IrsiCaixa: the legacy of past pandemics to face those of the future
Emerging pathogens 07/02/2025 Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses